1
Investors
About
Symbiomix Therapeutics, LLC is a biopharmaceutical company developing innovative medicines for gynecological infections, including their lead drug Solosec™ (secnidazole oral granules), a single-dose 5-nitroimidazole antibiotic.
Explore Symbiomix Therapeutics, LLC's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.